Metabolomics Workbench : NIH Data Repository

Analysis	Metabolite Name	Measured Value	Units	CASE_CONTROL	Chemotherapy	Drug	Race	TIMEPOINT	Tamoxyfen	Taxane
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	855582	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	881321	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	898127	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	911991	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	928215	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	929436	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	946879	Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	949578	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	952403	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	970466	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	970488	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	978072	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	997353	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	998186	Peak area	Case	N	Letrozole	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1001119	Peak area	Control	N	Exemestane	Black	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1004936	Peak area	Control	N	Letrozole	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1008687	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1019978	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1020266	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1024839	Peak area	Control	N	Exemestane	Black	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1027706	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1033962	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1039350	Peak area	Case	Y	Exemestane	Black	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1049331	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1055520	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1058207	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1061273	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1064761	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1067100	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1069888	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1090308	Peak area	Case	Y	Exemestane	Black	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1127592	Peak area	Case	N	Exemestane	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1129200	Peak area	Control	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1129405	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1129757	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1135328	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1136795	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1153135	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1162616	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1178140	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1182846	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1188901	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1189384	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1197355	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1230094	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1232656	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1243244	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1267637	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1270535	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1271818	Peak area	Control	Y	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1272948	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1275001	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1282685	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1292347	Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1305521	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1306850	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1314781	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1335059	Peak area	Control	N	Letrozole	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1341823	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1349598	Peak area	Case	N	Exemestane	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1371726	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1374536	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1382652	Peak area	Control	Y	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1384425	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1384903	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1395496	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1396415	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1427387	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1430226	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1445338	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1447985	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1470240	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1529631	Peak area	Control	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1531390	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1533387	Peak area	Control	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1552134	Peak area	Control	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1557544	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1569904	Peak area	Case	N	Letrozole	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1572871	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1575532	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1583273	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1596966	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1597646	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1611279	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1618522	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1621558	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1636606	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1638976	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1681976	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1787679	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1816585	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1818513	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1834889	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1849929	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1852973	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1856852	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1920121	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	1973969	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	2035279	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	PALMITATE (CAS# 57-10-3); (M-H)-	2438875	Peak area	Control	N	Letrozole	White	Baseline	Y	N